Fayez Sarofim & Co Portfolio holdings
AUM
$43.1B
1-Year Est. Return
14.97%
1 Year Est. Return
+14.97%
AUM
$41.7B
AUM Growth
+$1.46B
(+3.6%)
Holding
316
Top Buys
| 1 | +$209M | |
| 2 | +$166M | |
| 3 | +$143M | |
| 4 |
NVIDIA
NVDA
|
+$116M |
| 5 |
Eaton
ETN
|
+$68.2M |
Top Sells
| 1 | +$230M | |
| 2 | +$96.5M | |
| 3 | +$89.3M | |
| 4 |
Microsoft
MSFT
|
+$73.1M |
| 5 |
Coca-Cola
KO
|
+$52.5M |
Sector Composition
| 1 | Technology | 30.18% |
| 2 | Financials | 18.67% |
| 3 | Consumer Staples | 12.1% |
| 4 | Healthcare | 9.33% |
| 5 | Consumer Discretionary | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Organon & Co
OGN
$1.92B
| $205K | ﹤0.01% |
21,178
-130
|
|
||
302
Arthur J. Gallagher & Co
AJG
$63B
| $203K | ﹤0.01% |
634
|
|
||
303
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$43.6B
| $202K | ﹤0.01% |
2,200
|
|
||
304
American International
AIG
$41.4B
| $200K | ﹤0.01% |
2,339
-175
|
|
||
305
HP
HPQ
$23.7B
| $200K | ﹤0.01% |
8,180
|
|
||
306
Orion Group Holdings
ORN
$400M
| $178K | ﹤0.01% |
19,674
|
|
||
307
ON24
ONTF
$248M
| $89.2K | ﹤0.01% |
16,428
|
|
||
308
Nautilus Biotechnolgy
NAUT
$250M
| $32.6K | ﹤0.01% |
45,000
|
|
||
309
Becton Dickinson
BDX
$55.1B
| – | – |
-1,051
|
|
||
310
Bristol-Myers Squibb
BMY
$104B
| – | – |
-3,930
|
|
||
311
CenterPoint Energy
CNP
$25.1B
| – | – |
-100,766
|
|
||
312
Dow Inc
DOW
$17B
| – | – |
-7,677
|
|
||
313
EQT Corp
EQT
$38.2B
| – | – |
-4,107
|
|
||
314
Howard Hughes
HHH
$5.19B
| – | – |
-2,931
|
|
||
315
iShares Russell 1000 ETF
IWB
$45.5B
| – | – |
-1,344
|
|
||
316
Rio Tinto
RIO
$121B
| – | – |
-3,411
|
|